miscsubjectsAI governance
Evidence review

PT-141 and Statins: Evidence on Sexual Arousal Pathways

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-statins`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-statins

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-statins/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-statins/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-statins/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-statins/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Statins

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. You are reading about Statins — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

Why Statins matters for you

  1. Drug: Statins
  2. What it does: Lipid management; debated cognitive/muscle side effects in subset.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.44 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Statins and Male Sexual Health: A Retrospective Cohort Study (source s0)

Cohort study finding no association between statins and sexual dysfunction diagnoses.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Association between atorvastatin and erectile dysfunction (source s1)

Pharmacovigilance and MR analysis linking atorvastatin to ED.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Double-blind, placebo-controlled evaluation of the safety, efficacy and tolerability of PT-141 (source s14)

Human trial data on PT-141 for ED.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Statins · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 3 sources · swipe →chain 32289a980095 · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
human
Atorvastatin use is associated with increased risk of ED per pharmacovigilance and Mendelian randomization analysis.
sources: s1
human
Statin use was not associated with increased risk of gonadal or sexual dysfunction diagnoses in one retrospective cohort.
sources: s0
human
PT-141 induces statistically significant erectile responses versus placebo at doses >7 mg in human ED studies.
sources: s14
mechanistic
No human trials examine PT-141 in statin users.
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:07
PT-141 and Statins: Evidence on Sexual Arousal Pathways · 4 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Statins
Slug: pt-141-statins
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Statins","condition_key":"statins","primary_peptide":"pt-141","peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":["statins"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down if you have Statins
it output
{
  "slug": "pt-141-statins",
  "title": "PT-141 and Statins: Evidence on Sexual Arousal Pathways",
  "body": "## What's breaking down if you have Statins\n\nStatins primarily manage lipids by inhibiting HMG-CoA reductase. In subsets of users, debated effects include muscle symptoms and possible impacts on hormone synthesis due to reduced cholesterol availability, a precursor for sex hormones. One analysis links atorvastatin to increased erectile dysfunction reports via pharmacovigilance and Mendelian randomization (human data, mechanistic via hormone pathways). Another cohort found no association with gonadal or sexual dysfunction diagnoses. No direct degeneration profile matches the slug; layers center on potential CNS or hormonal signals affecting arousal rather than mechanical load.\n\n## Why PT-141 might help you\n\n1. You are reading about Statins — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts as a melanocortin receptor agonist primarily on CNS pathways for sexual arousal. If statin use contributes to reduced desire or arousal signals in your case, the compound engages central mechanisms rather than peripheral blood flow alone. Human trials show statistically significant erectile responses versus placebo at 
d0f775accb706a10
Machine verification: /api/articles/pt-141-statins/contributions
Ask this article · 6 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Atorvastatin use is associated with increased risk of ED per pharmacovigilance and Mendelian randomization analysis."?
ask pt-141-statins claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Statin use was not associated with increased risk of gonadal or sexual dysfunction diagnoses in one retrospective cohort."?
ask pt-141-statins claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "PT-141 induces statistically significant erectile responses versus placebo at doses >7 mg in human ED studies."?
ask pt-141-statins claim c3 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "No human trials examine PT-141 in statin users."?
ask pt-141-statins claim c4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 and Statins: Evidence on Sexual Arousal Pathways — and what would you need me to tell you first?
ask pt-141-statins condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 and Statins: Evidence on Sexual Arousal Pathways (studies vs anecdotes)?
ask pt-141-statins good bad experiences · paste includes §SELF
pt-141-statins · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 26000 tokens · $0 · 2 models
chain head bc6b5dfa2afacb43
write grok/grok-4.3 · 2026-06-30 01:07 · 26000 tok · 19d52c00cf20
voxel_divide owner · 2026-07-17 02:41 · 0 tok · bc6b5dfa2afa
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 12:56
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 12:54
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 12:30
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 12:27
PROTOCOL_RUN dispatch · 2026-06-30 01:08 · t_7wgao21q
PROTOCOL_RUN dispatch · 2026-06-30 01:08 · t_7wgao21q
view full ledger & cards →
REST + ledger
read GET /api/articles/pt-141-statins · GET /api/articles/pt-141-statins?format=post (the editable body)
create/replace POST /api/articles/pt-141-statins · PUT /api/articles/pt-141-statins (replace, keeps revision) · PATCH /api/articles/pt-141-statins (merge)
delete DELETE /api/articles/pt-141-statins
writes need header x-terminal-key
LLM bundle GET /api/articles/pt-141-statins/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim pt-141-statins|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…